These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4958797)

  • 21. Quantitative studies of mycobacterial populations in sputum and saliva.
    Yeager H; Lacy J; Smith LR; LeMaistre CA
    Am Rev Respir Dis; 1967 Jun; 95(6):998-1004. PubMed ID: 4961042
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance among previously treated tuberculosis patients, a brief report.
    Costello HD; Caras GJ; Snider DE
    Am Rev Respir Dis; 1980 Feb; 121(2):313-6. PubMed ID: 6767427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
    Tripathy SP; Menon NK; Mitchison DA; Narayana AS; Somasundaram PA; Stott H; Velu S
    Tubercle; 1969 Sep; 50(3):257-68. PubMed ID: 4981496
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of tuberculosis among the Orang Asli (Aborigines) in West Malaysia from 1951-1970.
    Bolton JM; Snelling MR
    Med J Malaysia; 1975 Sep; 30(1):10-29. PubMed ID: 813093
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of single and divided daily doses of isoniazid in original treatment of minimal and noncavitary moderately advanced pulmonary tuberculosis. XVIII. A report of the Veterans Administration-Armed Forces Cooperative Study on the chemotherapy of tuberculosis.
    Hyde L
    Am Rev Respir Dis; 1967 Aug; 96(2):204-8. PubMed ID: 4951906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract]   [Full Text] [Related]  

  • 28. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 30. Relapse in tuberculosis. A report from the Research Committee of the South-East Metropolitan Regional Thoracic Society.
    Br J Dis Chest; 1973 Jan; 67(1):33-42. PubMed ID: 4688044
    [No Abstract]   [Full Text] [Related]  

  • 31. Productivity of prolonged follow-up after chemotherapy for tuberculosis.
    Stead WW; Jurgens GH
    Am Rev Respir Dis; 1973 Aug; 108(2):314-20. PubMed ID: 4198349
    [No Abstract]   [Full Text] [Related]  

  • 32. Isoniazid plus thioacetazone compared with two regimens of isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis in South Indian patients.
    Tuberculosis Chemotherapy Centre
    Bull World Health Organ; 1966; 34(4):483-515. PubMed ID: 4161578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isoniazide-tiocarlide combination or DAT in the treatment of pulmonary tuberculosis. Comparison with isoniazide-PAS combination and especially BPAS].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1968; 32(3):371-80. PubMed ID: 5693998
    [No Abstract]   [Full Text] [Related]  

  • 34. [Controlled intermittent treatment of pulmonary tuberculosis using streptomycin, isoniazid and PAS once, twice or 3 times a week].
    el-Fassi el-Fahri M; Burzoni FJ; Durante C; Ceicu A
    Bull Int Union Tuberc; 1973 Dec; 48 Suppl():158-65. PubMed ID: 4611550
    [No Abstract]   [Full Text] [Related]  

  • 35. A preliminary trial of lividomycin in patients with pulmonary tuberculosis.
    Tsukamura M
    Tubercle; 1972 Mar; 53(1):43-6. PubMed ID: 5038199
    [No Abstract]   [Full Text] [Related]  

  • 36. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.
    Who Collaborating Centre For Tuberculosis Chemotherapy
    Bull World Health Organ; 1973; 48(2):155-65. PubMed ID: 4578361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Observations on cases with minimal tuberculosis of doubtful activity with or without chemotherapy].
    Grant
    Z Tuberk Erkr Thoraxorg; 1966; 125(3):198-201. PubMed ID: 6014523
    [No Abstract]   [Full Text] [Related]  

  • 39. [The open healing of cavities].
    Langer C
    Wien Med Wochenschr; 1966 Sep; 116(38):776-9. PubMed ID: 4965686
    [No Abstract]   [Full Text] [Related]  

  • 40. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.